AbstractHIVINTEREST 2020Durability of Second-line Anti-Retroviral Therapy and Predictors of a Viral Rebound Among HIV Patients on Second-line ART in an HIV Specialist Clinic in Uganda: A 10-Year Retrospective CohortView Abstract
AbstractHIVINTEREST 2020Virological suppression among HIV infected adolescents and youths receiving ART in the National teaching and referral hospital in Kenya.View Abstract
AbstractHIVINTEREST 2020Comparative study on the liver profile of HIV positive pregnant women and HIV positive non-pregnant women attending the Bamenda Regional Hospital, CameroonView Abstract
AbstractHIVINTEREST 2020Limited increase in primary HIV‐1C drug resistance mutations in treatment naïve individuals in EthiopiaView Abstract
AbstractHIVINTEREST 2020Acceptability of Quadrimune, a new Abacavir/Lamivudine/Lopinavir/Ritonavir paediatric fixed dose combinationView Abstract
AbstractHIVINTEREST 2020Improving linkage to antiretroviral therapy using a peer attachment model in selected facilities in the Southern Highland Zone of TanzaniaView Abstract
AbstractHIVINTEREST 2020The effect of home-based care in achieving viral load coverage in two high volume facilities in Akwa Ibom state, NigeriaView Abstract
AbstractHIVINTEREST 2020Improving retention in ART care using Call-2Care© approach: A snapshot from Defence Forces of Zambia (DFZ)View Abstract
AbstractHIVINTEREST 2020Factors associated with unsuppressed viral load among patients enrolled in the Community HIV Care Program in Botswana. A retrospective cross-sectional study.View Abstract
AbstractHIVINTEREST 2020Minimal cross-resistance to tenofovir in children and adolescents failing abacavir-based ART makes them eligible for tenofovir-lamivudine-dolutegravir treatment.View Abstract
AbstractHIVINTEREST 2020"You are not benefiting us by keeping us away": Why do some eligible people on antiretroviral therapy (ART) decline to participate in Ethiopia's appointment spacing model with 6-month ART dispensing?View Abstract
